Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy

BackgroundOfatumumab, a fully humanized anti-CD20 monoclonal antibody, has shown promising efficacy in limited cases of neuromyelitis optica spectrum disorder, but there is a lack of studies on its use in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. We present a case of refracto...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Shugang Cao, Jing Du, Sidi Pan, Juanjuan Zhang, Si Xu, Ling Wei, Yanghua Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Subjects:	glial fibrillary acidic protein astrocytopathy ofatumumab rituximab safety efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1164181/full